Wits RHI
Publications 2015 - 2024
Infectious Diseases
Filter by
HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084
Fogel JM, Persaud D, Piwowar-Manning E, Richardson P, Szewczyk J, Marzinke MA, Wang Z, Guo X, McCauley M, Farrior J, Tran HV, Ungsedhapand C, Mathew CA, Mpendo J, Rinehart AR, Rooney JF, Cohen MS, Hanscom B, Grinsztejn B, Hosseinipour MC, Delany-Moretlwe S, Landovitz RJ, Eshleman SH, HPTN 083 and HPTN…
South African Parents’ and Grandparents’ Perspectives on the Acceptability of Implant Delivery of Treatment to Young Children with HIV
Hawley I, Baez A, Scorgie F, Fairlie L, Mathebula F, Cottrell ML, Johnson LM, Montgomery ET.(2024)
Preferences for oral and injectable PrEP among qualitative sub-study participants in HPTN 084
Tolley EE, Bula A, Chitukuta M, Ndimande-Khoza N, Etima J, Namey E, Kemigisha D, Makhale L, Tsidya M, Shoen M, Hosseinipour MC, Delany- Moretlwe S, HPTN 084 study team. (2024)
From policy to practice: Experiences from the ECHO trial following revisions of the WHO medical eligibility criteria for contraceptive use (MEC) guidance on DMPA-IM
Steyn P, Beksinska M, Pleaner M, Tam H, Smit J, Baisley K, Taylor D, Singata-Madliki M, Hofmeyr GJ, Palanee-Phillips T, Kiarie JN. (2024)
The impact of COVID-19 restrictions on HIV prevention and treatment services for key populations in South Africa: an interrupted time series analysis
Yao D, Hill N, Brown B, Gule D, Chabane M, Mcingana M, Willis K, Shiba V, Olawore O, Nel D, Pienaar J, Theunissen J, Rucinski K, Reichert K, Parmley L, Lawrence JJ, Baral, Ra A. (2024)
True and false positive HIV point of care test results in a prospective multinational study of at-risk African women: implications for large-scale repeat HIV testing in HIV prevention programs
Morrison S, Batting J, Wanga V, Beesham I, Deese J, Hofmeyr GJ, Kasaro MP, Louw C, Morrison C, Mugo NR, Palanee-Phillips T, Pleaner M, Reddy K, Scoville CW, Smit J, Stringer JSA, Ahmed K, Bukusi E, Kotze P, Baeten JM; ECHO Trial Team.(2024)
Growth Trajectories Over the First Year of Life Among Early-Treated Infants with Human Immunodeficiency Virus and Infants Who are Human Immunodeficiency Virus-Exposed Uninfected
Barrios-Tascon A, Strehlau R, Patel F, Burke M, Shiau S, Shen Y, Arpadi SM, Abrams EJ, Tiemessen CT, Kuhn L, LEOPARD study team. (2024)
Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression
Morrison CS, Hofmeyr GJ, Thomas KK, Rees H, Philip N, Palanee-Phillips T, Nanda K, Nair G, Onono M, Mastro TD, Lind M, Heffron R, Edward V, Deese J, Beksinska M, Beesham I, Stringer J, Baeten J, Ahmed K.Morrison CS
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women
Bekker LG, Das M, Abdool Karim Q, Ahmed K, Brumskine W, Gill K, Harkoo I, Jaggernath M, Kigozi G, Kiwanuka N, Kotze P, Lebina L, Cheryl E Louw CE, Malahleha M, Manentsa M, Mansoor LE, Moodley D, Naicker V, Naidoo L, Naidoo M, Nair G, Ndlovu N, Palanee-Phillips T, Panchia…
Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trial
Dadabhai S, Chou VB, Pinilla M, Chinula L, Owor M, Violari A, Moodley D, Stranix-Chibanda L, Matubu TA, Chareka GT, Theron G, Kinikar AA, Mubiana-Mbewe M, Fairlie L, Bobat R, Mmbaga BT, Flynn PM, Taha TE, McCarthy KS, Browning R, Mofenson LM, Brummel SS, Fowler MG; IMPAACT PROMISE 1077BF/FF team.…
Effectiveness of integrating HIV prevention within sexual reproductive health (SRH) services with or without peer support amongst adolescents and young adults in rural KwaZulu-Natal: Isisekelo Sempilo 2×2 factorial randomised controlled trial
Shahmanesh M, Chimbindi N, Busang J, Chidumwa G, Mthiyani N, Herbst C, Okesola N, Dreyer J, Zuma T, Luthuli M, Gumede D, Hlongwane S, Mdluli S, Msane S, Smit T, Molina JM, Khoza T, Behuhuma NO, McGrath N, Seeley J, Harling G, Sherr L, Copas A, Baisley K. (2024)
Generalizing the intention-to-treat effect of an active control from historical placebo-controlled trials: A case study of the efficacy of daily oral TDF/FTC in the HPTN 084 study
He Q, Gao F, Dukes O, Delany-Moretlwe S, Zhang B. (2024)
Integrating a mental health intervention into PrEP services for South African young women: A human-centered implementation research approach to intervention development
Velloza J, Khoza N, Mills L, Concepcion T, Gumede S, Chauke H, Verhey R, Chibanda D, Hosek S, Weiner B, Celum, C, Delany-Moretlwe S. (2024)
Prevention method preferences and factors influencing hypothetical choice among women in South Africa: a survey exploring opportunities for a multipurpose prevention technology implant
Martin CE, Kutywayo A, Mataboge P, Chidumwa G, Mthimkhulu N, Bothma R, Mullick S. (2024)
Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study)
Ngure K, Friedland BA, Szydlo DW, Roberts ST, Garcia M, Levy L, Akello CA, Reddy K, Palanee-Phillips T, Macdonald P, Siziba B, Soto-Torres L, Hosek S, Hillier SL, Nair G, Celum C, van der Straten A. (2024)
Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants.
Jacobson DL, Crider KS, DeMarrais P, Brummel S, Zhang M, Pfeiffer CM, Moore CA, McCarthy K, Johnston B, Mohammed T, Vhembo T, Kabugho E, Muzorah GA, Cassim H, Fairlie L, Machado ES, Ngocho JS, Shapiro RL, Serghides L, Chakhtoura N, Chinula L, Lockman S. (2024)
Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV
Fairlie L, Brummel S, Ziemba L, Coletti A, Chinula L, Shapiro R, Stringer J, Browning R, Chakhtoura N, Mmbaga BT, Mhembere TP, Omoz-Oarhe A, Nagaddya B, Naidoo M, Lockman S, for the IMPAACT 2010/VESTED Study Team. (2024)
Safety, Effectiveness and Immunogenicity of heterologous mRNA-1273 Boost after Prime with Ad26.COV2.S among Healthcare Workers in South Africa: the single-arm, open-label, Phase 3 SHERPA Study
Garrett N, Reddy T, Yende-Zuma N, Takalani A, Woeber K, Bodenstein A, Jonas P, Enelbrecht I, Jassat W, Moultrie H, Bradshaw D, Seocharan I, Odhiambo J, Khuto K, Richardson SI, Omandi MA, Nesamari R, Keeton RS, Riou C, Moyo-Gwete T, Innes C, Barnabas S, Lombaard J, Gill K, Nchabeleng M,…
Correlates of adherence to oral and vaginal pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) participating in the MTN-034/REACH Trial
Ngure K, Browne E, Reddy K, Friedland BA, van der Straten A, Palanee-Philips T, Nakalega R, Gati B, Nabunya HK, Siziba B, Soto-Torres L, Nair G, Garcia M, Celum C, Roberts ST. (2024)
Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis
Broshkevitch C, Barnabas RV, Liu G, Palanee-Phillips T, Rao DW. (2024)
History of Rectal Product Use and Country of Residence Influence Preference for Rectal Microbicide Dosage Forms Among Young Sexual and Gender Minorities: A Multi-country Trial Comparing Placebo Douche, Suppository, and Insert Products
Han K, Patel P, McCallister S, Rinehart AR, Gandhi Y, Spreen W, Landovitz RJ, Delany-Moretlwe S, Marzinke MA, McKeon T, Budnik P, van Wyk J, Ford SL. (2024)
Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: data from the ECHO randomized trial
Hofmeyr GJ, Sangata-Madliki M, Batting J, Steyn P, Thomas KK, Issema R, Beesham I, Mbatsane E, Morrison C, Deese J, Smit J, Philip N, Palanee-Phillips T, Reddy K, Onono M, Mastro T, Baeten JM ECHO randomized trial. (2024)
Long-Acting Cabotegravir Pharmacokinetics With And Without Oral Lead-In For HIV PrEP
Han K, Patel P, McCallister S, Rinehart AR, Gandhi Y, Spreen W, Landovitz RL, Delany-Moretlwe S, Marzinke MA, McKeon T, Budnik P, van Wyk J, Ford SL. (2024)
Community beliefs and practices during pregnancy and their potential effect on HIV prevention product use in Sub-Saharan Africa
Mutero P, Young AM, Ryan JH, Reddy K, Kemigisha D, Gondwe D, Dandadzi A, Musara P. (2024)
Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study
Cholo FA, Dada S, Martin CE, Mullick S. (2024)
Cost-effectiveness of single-visit cervical cancer screening in KwaZulu-Natal, South Africa: a model-based analysis accounting for the HIV epidemic
Tran J, Hathaway CL, Broshkevitch CJ, Palanee-Phillips T, Barnabas RV, Rao DW, Sharma M. (2024)
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
Gaur AH, Capparelli EV, Calabrese K, Baltrusaitis K, Marzinke MA, McCoig C, Van Solingen-Ristea RM, Mathiba SR, Adeyeye A, Moye JH, Heckman B…IMPAACT 2017 Collaborators, IMPAACT 2017 Team. (2024)
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants PGPH-D-23-02273R1
Riou C, Bhiman JN, Ganga Y, Sawry S, Ayres F, Baguma R, Balla SR, Benede N, Bernstein M, Besethi AS, Cele S, Crowther C, Dhar M, Geyer S, Gill K, Grifoni A, Hermanus T, Kaldine H, Keeton RS, Kgagudi P, Khan K, Lazarus E, Roux JL, Lustig G, Madzivhandila M,Mzindle…
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study
Lowenthal ED, Chapman J, Ohrenschall R, Calabrese K, Baltrusaitis K, Heckman B, Yin DE, Agwu AL, Harrington C, Van Solingen-Ristea RM, McCoig CC, Adeyeye A, Kneebone J, Chounta V, Smith-Anderson C, Camacho-Gonzalez A, D’Angelo J, Bearden A, Crauwels H, Huang J, Buisson S, Milligan R, Ward S, Bolton-Moore C, Gaur…
Depression Among Pregnant and Breastfeeding Persons Participating in Two Randomized Trials of the Dapivirine Vaginal Ring and Oral Pre-Exposure Prophylaxis (PrEP) in Malawi, South Africa, Uganda, and Zimbabwe
Stoner MCD, Mathebula F, Sedze N, Seyama L, Mohuba R, Fabiano Z, Etima J, Young A, Scheckter R, van der Straten A, Piper J, Noguchi L, Montgomery ET, Balán IC. (2024)
A conjoint experiment of three placebo rectal products used with receptive anal sex: results from MTN-035
Bauermeister J, Lin W, Tingler R, Liu A, Chariyalertsak S, Hoesley C, Gonzales P, Ho K, Kayange N, Palanee Phillips T, Johnson S, Brown E, Zemanek J, Jacobson CE, Gustavo F Doncel GF, Piper J, MTN-035 Protocol Team for the Microbicide Trials Network. (2024)
Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study
Sawry S, Ayalew K, Maimela G, Briggs-Hagen M, van Wyk-Heath M, Mthethwa S, Shai S, Mngomezulu NN, Tlhowe L, Achere-Darko J, Bedford J, Martin CE, Fairlie L, Imrie J. (2024)
The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants
Johnson LF, Myer L, Jamieson L, Meyer-Rath G, Delany-Moretlwe S, Joseph Davey D. (2024)
Assessing the acceptability of, adherence to and preference for a dual prevention pill (DPP) for HIV and pregnancy prevention compared to oral pre-exposure prophylaxis (PrEP) and oral contraception taken separately: protocols for two randomised, controlled, cross-over studies in South Africa and Zimbabwe
Friedland BA, Mgodi NM, Palanee-Phillips T, Mathur S, Plagianos MG, Bruce IV, Lansiaux M, Murombedzi C, Musara P, Dandadzi A, Reddy K, Ndlovu N, Zulu SK, Shale LR, Zieman B, Haddad LB. (2024)
Implementation preferences for the management of sexually transmitted infections in the South African health system: a discrete choice experiment
Iwuji C, Martin CE, Pillay D, Shamu P, Nzenze S, Murire M, Cox LA, Miners A, Llewellyn C, Mullick S. (2024)
Final 192-week efficacy and safety results of the ADVANCE trial, comparing three first-line antiretroviral regimens
Sokhela S, Venter WD, Bosch B, Woods J, McCann K, Akpomiemie G, Chandiwana N, Mashabane N, Tembo A, Simmons B, Lalla-Edward S, Siedner M, Sinxadi P, Hermans L, Fairlie L, Vos A, Abrams E, Manne-Goehler JM, Moorhouse M, Clayden P, Norris S, Qavi A, Chersich M, Masenya M, Arulappan N,…
Obstetric and neonatal outcomes in South Africa
Cutland CL, Sawry S, Fairlie L, Barnabas S, Frajzyngier V, Roux JL, Izu A, Kekane-Mochwari KE, Vika C, De Jager J, Munson S, Jongihlati B, Stark JH, Absalon J. (2024)
Point-of-care testing for sexually transmitted infections and HIV pre-exposure prophylaxis among pregnant women in South Africa, 2021-2022: randomised controlled trial
de Voux A, Nyemba DC, Silliman M, Mashele N, Mvududu R, Myer L, Joseph Davey D. (2024)
Clot Twist – D-dimer analysis of healthy adults receiving heterologous or homologous booster COVID-19 vaccine after a single prime dose of Ad26.COV2.S in a phase II randomised open-label trial, BaSiS.
Patel F, Le Roux J, Sawry S, Kieser R, Dhar M, Gill K, Lazarus E, Nana A, Garrett N, Moore PL, Sigal A, Gray G, Rees HV, Jacobson BF, Fairlie L. (2024)
Key programmatic and policy considerations for introducing multipurpose prevention (MPT) methods: reflections from healthcare providers and key stakeholders in South Africa
Kutywayo A, Mataboge P, Mthimkhulu N, Martin CE, Muhwava LS, Mazibuko M, Makalela N, Kwatsha K, Butler V, Mullick S. (2024)
HIV Drug Resistance Assessment among Women who Seroconverted during the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial
Parikh UM, Penrose KJ, Heaps AL, Sethi R, Goetz BJ, Szydlo D, Chandran U, Palanee-Phillips T, Mgodi NM, Baeten JM, Mellors JW, MTN-025/HOPE Study Team. (2024)
Virtual case management: a differentiated approach to HIV prevention, treatment, and care
Zinck MJ, Minichiello SN, Fick CA, Sawry S, Fonner VA. (2024)
DELIVER: A Safety Study of a Dapivirine Vaginal Ring and Oral PrEP for the Prevention of HIV During Pregnancy
Bunge K, Balkus JE, Fairlie L, Mayo AJ, Nakabiito C, Mgodi N, Gadama L, Matrimbira M, Chappell CA, Piper J, Chakhtoura N. (2024)
Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum
Brummel S, Ziemba L, Chinula L, McCarthy K, Fairlie L, Jean-Philippe P, Chakhtoura N, Johnston B, Krotje C, Nematadzira TG, Nakayiwa F, Ndyanabangi V, Hanley S, Theron G, Violari A, João E, Correa Junior MD, Hofer CB, Navanukroh O, Aurpibul L, Nevrekar N, Zash R, Shapiro R, Stringer JSA, Currier…
Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex
Browne EN, Torjesen K, Mirembe BG, Palanee-Phillips T, Jeenarain N, Chitukuta M, Stoner MCD, Mansoor LE, Reddy K, Tauya TT, Naidoo L, Siva S, Richardson B, Dadabhai S, Seyama L, Soto-Torres L, van der Straten A; MTN-020/ASPIRE Study Team. (2024)
The Effect of Disclosure of PrEP Use on Adherence Among African Young Women in an Open-Label PrEP Study: Findings from HPTN 082
Beauchamp G, Hosek S, Donnell D, Chan KCG, Anderson PL, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C, HPTN 082 study team. (2024)
“What if I get sick, where shall I go?”: a qualitative investigation of healthcare engagement among young gay and bisexual men in Nairobi, Kenya
Mwaniki SW, Kaberia PM, Mugo PM, Palanee-Phillips T. (2024)
Pregnancy outcomes following self-reported and objective-measured exposure to oral preexposure prophylaxis in South Africa: an observational cohort study
Davey DLJ, Nyemba DC, Mvududu R, Mashele N, Johnson L, Bekker LG, Dean SS, Bheemraj K, Coates TJ, Myer L. (2023)
Factors influencing the uptake of a mono-PrEP implant for the prevention of HIV: Males’ perspectives from three South African provinces’
Mthimkhulu N, Chidumwa G, Kutywayo A, Mataboge P, Martin CE, Kwatsha K, Makalela N, Mazibuko M, Butler V, Mullick S. (2024)
Brief Report: HIV Drug Resistance Assessment Among Women Who Seroconverted During the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial
Parikh UM, Penrose KJ, Heaps AL, Sethi R, Goetz BJ, Szydlo D, Chandran U, Palanee-Phillips T, Mgodi NM, Baeten JM, Mellors JW; MTN-025/HOPE Study Team. (2024)
Post-randomization Differences in Condomless Vaginal Sex Among Women Randomized to Intramuscular Depot Medroxyprogesterone Acetate Injections, a Copper Intrauterine Device or a Levonorgestrel Implant in the ECHO Trial
Deese J, Chen PL, Gao X, Heffron R, Hobbs M, Lapple D, Jaspan H, Miller A, Nair G, Onono M, Palanee-Phillips T, Reddy K, Steiner MJ. (2023)
The Effect of Disclosure of PrEP Use on Adherence Among African Young Women in an Open-Label PrEP Study: Findings from HPTN 082
Beauchamp G, Hosek S, Donnell D, Chan KCG, Anderson PL, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C; HPTN 082 study team. (2023)
Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa
Khadka N, Gorbach PM, Nyemba DC, Mvududu R, Mashele N, Javanbakht M, Nianogo RA, Aldrovandi GM, Bekker L-G, Coates TJ, Myer L and Joseph Davey DL. (2023)
The use of HIV pre-exposure prophylaxis among men accessing routine sexual and reproductive health services in South Africa
Cox LA, Martin CE, Nongena P, Mvelase S, Kutywayo A, Mullick S. (2023)
Implementing differentiated and integrated PrEP services for adolescent key populations: what works and what’s next?
Butler V, Kutywayo A, Martin CE, Pleaner M, Mojapele MV, Ncube S, Fipaza Z, Mundeta B, Mullick S. (2023)
Implementing Differentiated and Integrated HIV Prevention Services for Adolescent Girls and Young Women: Experiences From Oral PrEP Rollout in Primary Care Services in South Africa
Butler V, Kutywayo A, Martin CE, Pleaner M, Mojapele MV, Ncube S, Fipaza Z, Mundeta B, Mullick S. (2023)
Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa
Ndimande-Khoza MN, Katz AWK, Moretlwe-Delany S, Travill D, Rousseau E, Omollo V, Morton J, Johnson R, Bekker LG, Bukusi EA, Baeten J, Celum C, van der Straten A, Roberts ST. (2023)
Comparing the integration of syndromic versus aetiological management of Sexually Transmitted Infections into HIV Pre-exposure Prophylaxis services for adolescent girls and young women in South Africa
Mullick S, Cox LA, Martin CE, Fipaza Z, Ncube S. (2023)
Patterns of HIV pre-exposure prophylaxis use among adolescent girls and young women accessing routine sexual and reproductive health services in South Africa
Martin CE, Cox LA, Nongena P, Butler V, Ncube S, Sawry S, Mullick S. (2023)
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, openlabel, crossover trial
Nair G, Celum C, Szydlo D, Brown ER, Akello CA, Nakalega R, Macdonald P, Milan G, Palanee-Phillips T, Reddy K, Tahuringana E, Muhlanga F, Nakabito C, Bekker L, Siziba B, Hillier SL, Baeten JM, Garcia M, Johnson S, McClure T, Levy L, Livant T, Jacobson C, Soto-Torres L, van der…
More Frequent HIV Viral Load Testing With Point-Of-Care Tests Detects Elevated Viral Load Earlier in Postpartum HIV-Positive Women in a Randomized Controlled Trial in Two Clinics in Johannesburg, South Africa
Fairlie L, Sawry S, Pals S, Sherman G, Williamson D, Le Roux J, Ngeno B, Berrie L, Diallo K, Cox MH, Mogashoa M, Chersich M, Modi S, OPPTIM (Optimised Postpartum PMTCT Testing for Infants and their Mothers) Study Team. (2023)
High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial
Delany-Moretlwe S, Mgodi N, Bekker LG, Baeten JM, Li C, Donnell D, Agyei Y, Lennon D, Rose SM, Mokgatle M, Kassim S, Mukaka S, Adeyeye A, Celum C. (2023)
Preferences, educational messaging, and demand creation channels for multipurpose- prevention technologies (MPTs) among women in South Africa
Mataboge P, Mthimkhulu N, Kutywayo A, Martin CE, Mazibuko M, Kwatsha K, Makalela N, Briedenhann E, Butler V, Bothma R, Mullick S. (2023)
Prevalence of curable sexually transmitted infections in a population-representative sample of young adults in a high HIV incidence area in South Africa
Jana J, Chidumwa G, Chimbindi N, Okesola N, Dreyer J, Smit T, Seeley J, Harling G, Copas A, Baisley K, Shahmanesh M, Herbst C, McGrath N, Zuma T, Khoza T, Behuhuma N, Bassett IV, Sherr L. (2023)
Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherence
Moore M, Stansfield S, Donnell DJ, Boily MC, Mitchell KM, Anderson PL, Delany-Moretlwe S, Bekker LG, Mgodi NM, Celum CL, Dimitrov D. (2023)
Microbiota in the oral cavity of school-age children with HIV who started antiretroviral therapy at young ages in South Africa
Kuhn L, Wang T, Li F, Strehlau R, Tobin NH, Violari A, Brooker S, Patel F, Liberty A, Shiau S, Arpadi SM, Wadhwa S, Yin MT, Wang S, Tiemessen CT, Aldrovandi GM (2023)
Intimate Partner Violence and Engagement in the HIV Care Continuum among Women in Sub-Saharan Africa: A Prospective Cohort Study
Roberts ST, van der Straten A, Rael CT, Gorbach PM, Palanee-Phillips T, Reddy K, Naidoo K, Dadabhai S, Chinula L, Gaffoor Z, Levy L, Balkus JE, Riddler SA. (2023)
Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
Donnell D, Gao F, Hughes JP, Hanscom B, Corey L, Cohen MS, Edupuganti S, Mgodi N, Rees H, Baeten JM, Gray G, Bekker LG, Hosseinipour M, Delany-Moretlwe S. (2023)
T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa
McMahon WC, Kwatra G, Izu A, Koen AL, Greffrath J, Fairlie L, Patel F, Mukendi CK, Mbele NJ, Lala R, Burgers WA, Nunes MC, Cutland CL, Gilbert SC, Lambe T, Pollard AJ, Madhi SA. (2023)
Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda
Stoner MCD, Hawley I, Mathebula F, Horne E, Etima J, Kemigisha D, Mutero P, Dandadzi A, Seyama L, Fabiano Z, Scheckter R, Noguchi L, Owor M, Balkus JE, Montgomery ET. (2023)
Adolescent Girls and Young Women’s Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis
Young AM, Mancuso N, Atujuna M, Tenza S, Chitukuta M, Kemigisha D, Ngure K, van der Straten A, Garcia M, Szydlo D, Soto-Torres L, Roberts ST. (2023)
Integrating Gender-Based Violence Screening and Support into the Research Clinic Setting: Experiences from an HIV Prevention Open-Label Extension Trial in Sub-Saharan Africa
Garcia M, Roberts ST, Mayo AJ, Scheckter R, Mansoor LE, Palanee-Phillips T, Reddy K, Naidoo Y, Akello CA, Gaffoor Z, Siva S, Rushwaya C, Hlahla K, Jambaya J, Makoni R, Kachale E, Ndovie M, Zuma J, Montgomery ET; MTN-025/HOPE study team. (2023)
Examining Associations Between Mental Health, IPV Exposure, HIV Risk Behaviors, and PrEP Use in South African Women: An Analysis of Data from the Charisma Study
Triplett NS, Roberts ST, Hartmann M, Wagner D, Reddy KR, Mathebula F, Tolley EE, Baeten JM, Palanee-Phillips T, Montgomery ET. (2023)
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents
Chandasana H, Thapar M, Hayes S, Baker M, Gibb DM, Turkova A, Ford D, Ruel T, Wiznia A, Fairlie L, Bwakura-Dangarembizi M, Mujuru H, Alvero C, Farhad M, Hazra R, Townley E, Buchanan A, Bollen P, Waalewijn H, Colbers A, Burger D, Acosta EP, Singh R; IMPAACT P1093, ODYSSEY (PENTA…
Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review
Bhushan NL, Ridgeway K, Luecke EH, Palanee-Phillips T, Montgomery ET, Minnis AM. (2023)
Measuring Effects of Counseling to Increase Pre-Exposure Prophylaxis Adherence and Partner Support in South Africa Using the Healthy Relationship Assessment Tool
Zissette S, Tolley EE, Martinez A, Roberts ST, Palanee-Phillips T, Elizabeth T Montgomery ET. (2023)
Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex
Browne EN, Torjesen K, Mirembe BG, Palanee-Phillips T, Jeenarain N, Chitukuta M, Stoner MCD, Mansoor LE, Reddy K, Tauya TT, Naidoo L, Siva S, Richardson B, Dadabhai S, Seyama L, Soto-Torres L, van der Straten A on behalf of the MTN-020/ASPIRE Study Team. (2023)
Clinical outcomes of intrauterine device insertions by newly trained providers: The ECHO trial experience
Yacobson I, Wanga V, Ahmed K, Chipato T, Gichangi P, Kiarie J, Louw C, Morrison S, Moss M, Mugo NR, Palanee-Phillips T, Pleaner M, Scoville CW, Thomas KK, Nanda K; Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. (2023)
State-of-the-Science of Human Papillomavirus Vaccination in Women with Human Immunodeficiency Virus: Summary of a Scientific Workshop
Schuind A, Rees H, Schiller J, Mugo N, Dull P, Barnabas R, Clifford G, Liu G; Madhi S, Morse R; Moscicki A, Palefsky J, Plotkin S, Sierra M, Slifka M, Vorsters A, Kreimer A, Didierlaurent A. (2023)
Safety surveillance for PrEP in pregnant and breastfeeding women
Fairlie L, Lavies D, Kalk E, Mhlongo O, Patel F, Technau KG, Mahtab S, Moodley D, Subedar H, Mullick S, Sawry S. (2023)
HIV prevalence and associated risk factors among young tertiary student men who have sex with men (MSM) in Nairobi, Kenya: a respondent-driven sampling survey
Mwaniki SW, Kaberia PM, Mugo PM, Palanee-Phillips T. (2023)
Changes in relationships, HIV risk, and feelings towards PrEP: findings from a qualitative explanatory study among participants in the CHARISMA intervention trial
Hartmann M, Triplett N, Roberts ST, Lanham M, Reddy K, Tenza S, Mayisela N, Mbewe D, Maboa O, Mampuru L, Tolley EE, Palanee-Phillips T, Montgomery ET. (2023)
Trust in the provider and accurate self-reported PrEP adherence among adolescent girls and young women in South Africa and Zimbabwe: HPTN 082 study
Beauchamp G, Donnell D, Hosek S, Anderson PL, Chan KCG, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C. (2023)
Evaluating use of mass-media communication intervention ‘MTV-Shuga’ on increased awareness and demand for HIV and sexual health services by adolescent girls and young women in South Africa: an observational study
Chimbindi N, Mthiyane N, Chidumwa G, Zuma T, Dreyer J, Birdthistle I, Floyd S, Kyegombe N, Grundy C, Cawood C, Danaviah S, Smit T, Pillay D, Baisley K, Harling G, Seeley J, Shahmanesh M. (2023)
Optimizing the pipeline of multipurpose prevention technologies: opportunities across women’s reproductive lifespans
Bershteyn A, Resar D, Kim HY, Platais I, Mullick S. (2023)
HIV infection
Bekker LG, Beyrer C, Mgodi N, Lewin SR, Delany-Moretlwe S, Taiwo B, Masters MC, Lazarus JV. (2023)
Changes in the Vaginal Microbiome During Pregnancy and the Postpartum Period in South African Women: a Longitudinal Study
Li KT, Li F, Jaspan H, Nyemba D, Myer L, Aldrovandi G, Joseph-Davey D. (2023)
Eita! Reaching communities and young people to drive demand for oral PrEP in South Africa
Rosenberg P, Sheobalak N, Pleaner M, Martin C, Mullick S. (2023)
Mental health needs of adolescent and young adult PrEP users in South Africa: Implications for sexual and reproductive health programming
Gordon KJ, Martin CE, Kutywayo A, Cox LA, Nongena P, Mullick S. (2023)
Development of a relationship counselling website to identify and mitigate risk of intimate partner violence in the context of women’s PrEP use
Hartmann M, Roberts ST, Triplett N, Tenza S, Maboa O, Mampuru L, Mayisela N, Mbewe D, Tolley E, Reddy K, Palanee-Phillips T, Montgomery ET. (2023)
A decision support tool has similar high PrEP uptake and increases early PrEP persistence in adolescent girls and young women in South Africa: results from a randomized controlled trial
Celum C, Seidman D, Travill D, Dehlendorf C, Gumede S, Zewdie K, Wilson W, Morton JF, Baeten JM, Donnell D, Delany-Moretlwe S. (2023).
The importance of the “how”: the case for differentiated service delivery of long-acting and extended delivery regimens for HIV prevention and treatment
Grimsrud A, Wilkinson L, Delany-Moretlwe S, Ehrenkranz P, Green K, Murenga M, Ngure K, Otwoma NJ, Phanuphak N, Vandevelde W, Vitoria M, Bygrave H. (2023)
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study
Brooks KM, Kiser JJ, Ziemba L, Ward S, Rani Y, Cressey TR, Masheto GR, Cassim H, Deville JG, Ponatshego PL, Patel F, Aurpibul L, Barnabas SL, Mustich I, Coletti A, Heckman B, Krotje C, Lojacono M, Yin DE, Townley E, Moye J, Majji S, Acosta EP, Ryan K, Chandasana H,…
Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies
Wei F, Goodman MT, Xia N, Zhang J, Giuliano AR, D'Souza G, Hessol NA, Schim van der Loeff MF, Dai J, Neukam K, de Pokomandy A, Poynten IM, Geskus RB, Burgos J, Etienney I, Moscicki AB, Donà MG, Gillison ML, Nyitray AG, Nowak RG, Yunihastuti E, Zou H, Hidalgo-Tenorio C,…
Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections
Dabee S, Balle C, Onono M, Innes S, Nair G, Palanee-Phillips T, Burgener AD, Bosinger SE, Passmore JS, Heffron R, Jaspan H, Happel AU. (2023)
Association of sexual relationship power with PrEP persistence and other sexual health outcomes among adolescent and young women in Kenya and South Africa
Rousseau E, Wu L, Heffron R, Baeten JM, Celum CL, Travill D, Delany-Moretlwe S, Bekker LG, Bukusi E, Omollo V, van der Straten A, O'Malley G, Haberer JE, Morton JF, Johnson RE, Roberts ST. (2023)
Advancing use of long-acting and extended delivery HIV prevention and treatment regimens
Delany-Moretlwe S, Flexner C, Bauermeister JA. (2023)
Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
Donnell D, Gao F, Hughes JP, Hanscom B, Corey L, Cohen MS, Edupuganti S, Mgodi N, Rees H, Baeten JM, Gray G, Bekker LG, Hosseinipour M, Delany-Moretlwe S. (2023)
Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub-Saharan Africa community stakeholders
White RR, Dyer MC, Hosseinipour MC, Delany-Moretlwe S. (2023)
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus
Madhi SA, Anderson AS, Absalon J, Radley D, Simon R, Jongihlati B, Strehlau R, van Niekerk AM, Izu A, Naidoo N, Kwatra G, Ramsamy Y, Said M, Jones S, Jose L, Fairlie L, Barnabas SL, Newton R, Munson S, Jefferies Z, Pavliakova D, Silmon de Monerri NC, Gomme E, Perez…
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19
Kaplonek P, Cizmeci D, Kwatra G, Izu A, Lee JS, Bertera HL, Fischinger S, Mann C, Amanat F, Wang W, Koen AL, Fairlie L, Cutland CL, Ahmed K, Dheda K, Barnabas SL, Bhorat QE, Briner C, Krammer F, Saphire EO, Gilbert SC, Lambe T, Pollard AJ, Nunes M, Wuhrer M,…
The burden, prevention and care of infants and children with congenital anomalies in sub-Saharan Africa: A scoping review
Leke AZ, Malherbe H, Kalk E, Mehta U, Kisa P, Botto LD, Ayede I, Fairlie L, Maboh NM, Orioli I, Zash R, Kusolo R, Mumpe-Mwanja D, Serujogi R, Bongomin B, Osoro C, Dah C, Sentumbwe-Mugisha O, Shabani HK, Musoke P, Dolk H, Barlow-Mosha L. (2023)
Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study)
Ngure K, Friedland BA, Szydlo DW, Roberts ST, Garcia M, Levy L, Akello CA, Reddy K, Palanee-Phillips T, Macdonald P, Siziba B, Soto-Torres L, Hosek S, Hillier SL, Nair G, Celum C, van der Straten A. (2023)
Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda.
Stoner MC, Hawley I, Mathebula F, Horne E, Etima J, Kemigisha D, Mutero P, Dandadzi A, Seyama L, Fabiano Z, Scheckter R. (2023)
Brief Report: Dapivirine Ring HIV-1 Prevention Effectiveness for Women Engaged in Vaginal and Anal Intercourse: Insights From Mathematical Modeling
Peebles K, Brown ER, Hendrix CW, Palanee-Phillips T, van der Straten A, Harkoo I, Reddy K, Mirembe BG, Jeenarain N, Hillier SL, Baeten JM, Barnabas RV, MTN-020/ASPIRE study team. (2023)
A qualitative study of stakeholder and researcher perspectives of community engagement practices for HIV vaccine clinical trials in South Africa
Dietrich JJ, Munoz J, Tshabalala G, Makhale LM, Hornschuh S, Rentas F, Mulaudzi M, Laher F, Andrasik MP. (2023)
Editorial: Integration of HIV prevention with sexual and reproductive health services
Palanee-Phillips T. (2023)
Introduction and integration of PrEP and sexual and reproductive health services for young people: Health provider perspectives from South Africa
Pleaner M, Scorgie F, Martin C, Butler V, Muhwava L, Mojapele M, Mullick S. (2023)
Planning for decentralized, simplified prEP: Learnings from potential end users in Ga-Rankuwa, gauteng, South Africa
Mataboge P, Nzenze S, Mthimkhulu N, Mazibuko M, Kutywayo A, Butler V, Naidoo N, Mullick S. (2023)
No Woman Left Behind: Achieving Cervical Cancer Elimination Among Populations Living with HIV
Sharma K, Machalek D, Toh Z, Amenu D, Muchenget M, Nghlovu A, Mremi A, Mchome B, Vallely A, Denny L, Rees H, Garland S. (2023)
Qualitative Analysis Using Social Maps to Explore Young Women’s Experiences With Social Support of their Oral PrEP Use in Kenya and South Africa
Katz AWK, Roberts S, Rousseau E, Khoza MN, Mogaka F, Bukusi E, Delany-Moretlwe S, Bekker LG, Morton JF, Johnson R, Baeten JM, Celum C, van der Straten A. (2023)
Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysis
Stone J, Bothma R, Gomez GB, Eakle R, Mukandavire C, Subedar H, Fraser H, Boily MC, Schwartz S, Coetzee J, Otwombe K, Milovanovic M, Baral S, Johnson LF, Venter WDF, Rees H, Vickerman P. (2023)
Defining principles for a choice-based approach to HIV prevention
Williams KM, Miller N, Tutegyereize L, Olisa AL, Chakare T, Jeckonia P, Mullick S, Atieno MA, Nhamo D, Rademacher KH. (2023)
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
Chinula L, Ziemba L, Brummel S, McCarthy K, Coletti A, Krotje C, Johnston B, Knowles K, Moyo S, Stranix-Chibanda L, Hoffman R, Sax PE, Stringer J, Chakhtoura N, Jean-Philippe P, Korutaro V, Cassim H, Fairlie L, Masheto G, Boyce C, Frenkel LM, Amico KR, Purdue L, Shapiro R, Mmbaga BT,…
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study
Smith J, Bansi-Matharu L, Cambiano V, Dimitrov D, Bershteyn A, van de Vijver D, Kripke K, Revill P, Boily MC, Meyer-Rath G, Taramusi I, Lundgren JD, van Oosterhout JJ, Kuritzkes D, Schaefer R, Siedner MJ, Schapiro J, Delany-Moretlwe S, Landovitz RJ, Flexner C, Jordan M, Venter F, Radebe M, Ripin…
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study
Smith J, Bansi-Matharu L, Cambiano V, Dimitrov D, Bershteyn A, van de Vijver D, Kripke K, Revill P, Boily MC, Meyer-Rath G, Taramusi I, Lundgren JD, van Oosterhout JJ, Kuritzkes D, Schaefer R, Siedner MJ, Schapiro J, Delany-Moretlwe S, Landovitz RJ, Flexner C, Jordan M, Venter F, Radebe M, Ripin…
A randomized trial of safety, acceptability and adherence of three rectal microbicide placebo formulations among young sexual and gender minorities who engage in receptive anal intercourse (MTN-035)
Bauermeister JA, Dominguez Islas C, Jiao Y, Tingler R, Brown E, Zemanek J, Giguere R, Balan I, Johnson S, Macagna N, Lucas J, Rose M, Jacobson C, Collins C, Livant E, Singh D, Ho K, Hoesley C, Liu A, Kayange N, Palanee-Phillips T, Chariyalertsak S, Gonzales P, Piper J, MTN-035…
Copper intrauterine device increases vaginal concentrations of inflammatory anaerobes and depletes lactobacilli compared to hormonal options in a randomized trial
Brown BP, Feng C, Tanko RF, Jaumdally SZ, Bunjun R, Dabee S, Happel AU, Gasper M, Nyangahu DD, Onono M, Nair G, Palanee-Phillips T, Scoville CW, Heller K, Baeten JM, Bosinger SE, Burgener A, Passmore JS, Heffron R, Jaspan HB. (2023)
Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000-2020)
Yang L, Boily MC, Rönn MM, Obiri-Yeboah D, Morhason-Bello I, Meda N, Lompo O, Mayaud P, Pickles M, Brisson M, Hodgins C, Delany-Moretlwe S, Maheu-Giroux M. (2023)
Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 study
Beauchamp G, Hosek S, Donnell DJ, Chan KCG, Flaherty BP, Anderson PL, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C, HPTN 082 study team. (2023)
Integration of HIV Prevention with Sexual and Reproductive Health Services
Palanee-Phillips T. (2023)
Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial
Mugo NR, Stalter RM, Heffron R, Rees H, Scoville CW, Morrison C, Kourtis AP, Bukusi E, Beksinka M, Philip NM, Beesham I, Deese J, Edward V, Donnell D, Baeten JM, Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. (2021)
Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial.
Bunjun R, Ramla TF, Jaumdally SZ, Noël-Romas L, Ayele H, Brown BP, Gamieldien H, Harryparsad R, Dabee S, Nair G, Onono M, Palanee-Phillips T, Scoville CW, Heller KB, Baeten JM, Bosinger SE, Burgener A, Passmore JS, Jaspan H, Heffron R. (2022)
Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial
Mirembe BG, Cabrera MV, van der Straten A, Nakalega R, Cobbing M, Mgodi NM, Palanee-Phillips T, Mayo AJ, Dadabhai S, Mansoor LE, Siva S, Nair G, Chinula L, Akello CA, Nakabiito C, Soto-Torres LE, Baeten JM, Brown ER. (2022)
Efficacy and Action of the Dapivirine Vaginal Ring as Understood by Women Participating in an Open Label Extension Study
Naidoo K, T ME, Katz AW, Morgan G, Krishnaveni R, Lydia ST, Sarita N, Leila ME. (2022)
Correction to: Intimate Partner Violence and Engagement in the HIV Care Continuum among Women in Sub-Saharan Africa: A Prospective Cohort Study
Roberts ST, van der Straten A, Rael CT, Gorbach PM, Palanee-Phillips T, Reddy K, Naidoo K, Dadabhai S, Chinula L, Gaffoor Z, Levy L, Balkus JE, Riddler SA. (2022)
Adolescent girls and young women (AGYW) in sub-Saharan Africa may benefit from pre-exposure prophylaxis (PrEP), yet stigma may limit PrEP acceptance and continuation. We examined…
Munthali RJ, Stangl AL, Baron D, Barré I, Harvey S, Ramskin L, Colombini M, Naicker N, Kapiga S, Delany-Moretlwe S. (2022)
Safety data needed for concurrent use of ARV-based PrEP
Dunbar MS, Rodrigues J, Chatani M, Baeten JM, Hendrix CW, Palanee-Phillips T, van der Straten A, Mgodi N, Brown E, Makura C, Namwanje S, Torjesen K. (2022)
Effect of antiretroviral therapy care interruptions on mortality in children living with HIV: cohort study from Southern Africa
Davies C, Johnson L, Sawry S, Chimbetete C, Eley B, Vinikoor M, Technau KG, Ehmer J, Rabie H, Phiri S, Tanser F, Malisita K, Fatti G, Osler M, Wood R, Newton S, Haas A, Davies MA. (2022)
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case
Kochhar S, Barreira D, Beattie P, Cavaleri M, Cravioto A, Frick MW, Ginsberg AM, Hudson I, Kaslow DC, Kurtz S, Lienhardt C, Madhi SA, Morgan C, Momeni Y, Patel D, Rees H, Rogalski-Salter T, Schmidt A, Semete-Makokotlela B, Voss G, White RG, Zignol M, Giersing B. (2022)
Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before–after design
Machalek D, Rees H, Chikandiwa A, Munthali R, Travill D, Mbulawa Z, Petoumenos K, Delany-Moretlwe S, Kaldor J, HOPE Study team. (2022)
Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization
Liu G, Mugo NR, Brown ER, Mgodi NM, Chirenje ZM, Marrazzo JM, Winer RL, Mansoor L, Palanee-Phillips T, Siva SS, Naidoo L, Jeenarain N, Gaffoor Z, Nair GL, Selepe P, Nakabiito C, Mkhize B, Mirembe BG, Taljaard M, Panchia R, Baeten JM, Balkus JE, Hladik F, Celum CL, Barnabas RV.…
Ring-ing in the Future: Participant and Male Partner Perspectives Regarding Future Use of the Dapivirine Vaginal Ring for HIV Prevention
Reddy K, Mathebula F, Katz A, Luecke E, Tenza S, Palanee-Phillips T, Garcia M, Mansoor LE, Naidoo S, Morar N, Chitukuta M, Tsidya M, Montgomery ET, MTN-032 Study team. (2022)
Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap
Joseph Davey DL, Bekker LG, Bukusi EA, Chi BH, Delany-Moretlwe S, Goga A, Lyerly AD, Mgodi NM, Mugo N, Myer L, Noguchi LM, Stranix-Chibanda L, Slack C, Pintye J. (2022)
Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
Zacharopoulou P, Marchi E, Ogbe A, Robinson N, Brown H, Jones M, Parolini L, Pace M, Grayson N, Kaleebu P, Rees H, Fidler S, Goulder P, Klenerman P, Frater J. (2022)
Drug-releasing vaginal rings for HIV/STI and pregnancy prevention: A review of recent advances and clinical applications
Palanee-Phillips T, Baum MM, Moss JA, Clark MR, Nuttall J, Romano JW. (2021)
Evidence for use of a healthy relationships assessment tool in the CHARISMA pilot study
Tolley EE, Martinez A, Zissette S, Palanee-Phillips T, Mathebula F, Tenza S, Hartmann M, Montgomery ET. (2021)
Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial
Mugo NR, Stalter RM, Heffron R, Rees H, Scoville CW, Morrison C, Kourtis AP, Bukusi E, Beksinka M, Philip NM, Beesham I, Deese J, Edward V, Donnell D, Baeten JM, Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. (2021)
Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?
Bhavaraju N, Shears K, Schwartz K, Mullick S, Jeckonia P, Murungu J, Persaud U, Vij A, Torjesen K. (2021)
Sexual Attitudes, Beliefs, Practices, and HIV Risk During Pregnancy and Post-delivery: A Qualitative Study in Malawi, South Africa, Uganda, and Zimbabwe
Ryan JH, Young A, Musara P, Reddy K, Macagna N, Guma V, Seyama L, Piper J, van der Straten A, MTN- 041/MAMMA Study Team. (2021)
Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study.
Garcia M, Luecke E, Mayo AJ, Scheckter R, Ndase P, Kiweewa FM, Kemigisha D, Musara P, Mansoor LE, Singh N, Woeber K, Morar NS, Jeenarain N, Gaffoor Z, Gondwe DK, Makala Y, Fleurs L, Reddy K, Palanee-Phillips T, Baeten JM, van der Straten A, Soto-Torres L, Torjesen K. (2021)
Corrigendum: Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020
Bekker LG, Brown B, Joseph-Davey D, Gill K, Moorhouse M, Delany-Moretlwe S, Myer L, Orrell C, Rebe K, Francois Venter WD, Wallis CL. (2021)
Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy
Lokken EM, Mathur A, Bunge KE, Fairlie L, Beigi R, Noguchi LM, Balkus JE. (2021)
HIV-1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial.
Parikh UM, Penrose KJ, Heaps AL, Halvas EK, Goetz BJ, Gordon KC, Hardesty R, Sethi R, Schwarzmann W, Szydlo DW, Husnik MJ, Chandran U, Palanee-Phillips T, Baeten JM, Mellors JW, MTN-020 Study Team. (2021)
Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study
Garcia M, Luecke E, Mayo AJ, Scheckter R, Ndase P, Kiweewa FM, Kemigisha D, Musara P, Mansoor LE, Singh N, Woeber K, Morar NS, Jeenarain N, Gaffoor Z, Gondwe DK, Makala Y, Fleurs L, Reddy K, Palanee-Phillips T, Baeten JM, van der Straten A, Soto-Torres L, Torjesen K. (2021)
Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial
Etima J, Katz AWK, Duby Z, Garcia M, Palanee-Phillips T, Reddy K, Mathebula F, Zimba C, Mansoor LE, Singh D, Manengamambo E, Naidoo S, Soto-Torres L, Montgomery ET, MTN-020/ASPIRE, MTN 025/HOPE, MTN-032 Study teams. (2021)
Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research
Irungu E, Khoza N, Velloza J. (2021)
Adolescent girls and young womens PrEP user journey during an implementation science study in South Africa and Kenya
Rousseau E, Katz AWK, O'Rourke S, Bekker LG, Delany-Moretlwe S, Bukusi E, Travill D, Omollo V, Morton JF, O'Malley G, Haberer JE, Heffron R, Johnson R, Celum C, Baeten JM, van der Straten A. (2021)
Health Care Providers’ Attitudes Toward and Experiences Delivering Oral PrEP to Adolescent Girls and Young Women in Kenya, South Africa, and Zimbabwe
Lanham M, Ridgeway K, Mireku M, Nhamo D, Pillay D, Murire M, Stankevitz K, Kyongo J, Mullick S, OPTIONS Consortium Research Team. (2021)
Project BESPOKE (Integrated Bio-Behavioral Assessment of HIV and STI Among Young Tertiary Student Men Who Have Sex With Men in Nairobi, Kenya): A Respondent-Driven Sampling Survey Protocol
Mwaniki SW, Mugo PM, Palanee-Phillips T. (2021)
Children have been left behind during the HIV 90-90-90 strategy implementation in South Africa
Nyasulu JCY, Dunlop J, Pandya H, Slemming W, Fick C, Saloojee H. (2021)
Challenges in recruiting children to a multidrug-resistant TB prevention trial
Purchase S, Batist E, Mmile N, Nkosi S, Workman J, Martinson N, Fairlie L, Schaaf HS, Choo L, McGowan C, Crook AM, Seddon JA, Hesseling AC. (2021)
Predictors of impaired pulmonary function in people living with HIV in an urban African setting
van Riel SE, Klipstein-Grobusch K, Barth RE, Grobbee DE, Feldman C, Shaddock E, Stacey SL, Venter WDF, Vos AG. (2021)
Usability assessment of seven HIV self-test devices conducted with lay-users in Johannesburg, South Africa
Majam M, Mazzola L, Rhagnath N, Lalla-Edward ST, Mahomed R, Venter WDF, Fischer AE
Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa
Noguchi LM, Marrazzo JM, Richardson B, Hillier SL, Balkus JE, Palanee-Phillips T, Nair G, Panchia R, Piper J, Gomez K, Ramjee G, Chirenje M. (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B. 1.351 variant in South Africa
Madhi SA, Baillie VL, Cutland CL, Voysey M, Koen AL, Fairlie L, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE, Briner C. (2021)
Investigating the effect of COVID-19 dissemination on symptoms of anxiety and depression among university students
Vigo D, Jones L, Munthali R, Pei J, Westenberg J, Munro L, Judkowicz C, Wang AY, Van den Adel B, Dulai J, Krausz M, Auerbach RP, Bruffaerts R, Yatham L, Gadermann A, Rush B, Xie H, Pendakur K, Richardson C. (2021)
Evaluation of a mobile application to support HIV self-testing in Johannesburg, South Africa
Gous N, Fischer AE, Rhagnath N, Phatsoane M, Majam M, Lalla-Edward ST
Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern Africa
Wadley AL, Venter W, Moorhouse M, Akpomiemie G, Serenata C, Hill A, Sokhela S, Mqamelo N, Kamerman PR
Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern Africa
Tsondai PR, Braithewaite K, Fatti G, Bolton-Moore C, Chimbetete C, Rabie H, Phiri S, Sawry S, Eley B, Hobbins MA, Boulle A, Taghavi K, Sohn AH, Davies MA
Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial
Brown ER, Hendrix CW, van der Straten A, Kiweewa FM, Mgodi NM, Palanee‐Philips T, Marzinke MA, Bekker L‐G, Soto‐Torres L, Hillier SL, Baeten JM, the MTN‐020/ASPIRE Study Team
Age-specific risk scores do not improve HIV-1 prediction among women in South Africa
Peebles K, Palanee-Phillips T, Balkus JE, Beesham I, Makkan H, Deese J, Smit J, Heffron R, Morrison CS, Philip NM, Malahleha M, Kasaro M, Naidoo Y, Nielson T, Reddy K, Kotze P, Ahmed K, Rees H, Baeten JM, Barnabas RV; Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
Age-specific risk scores do not improve HIV-1 prediction among women in South Africa
Peebles K, Palanee-Phillips T, Balkus JE, Beesham I, Makkan H, Deese J, Smit J, Heffron R, Morrison CS, Philip NM, Malahleha M, Kasaro M, Naidoo Y, Nielson T, Reddy K, Kotze P, Ahmed K, Rees H, Baeten JM, Barnabas RV, Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.
Phone calls to retain research participants in follow up: effectiveness and determinants of reachability in an African setting
Draaijer M, Lalla-Edward ST, Venter WDF, Vos A
Essential medicine selection during the COVID-19 pandemic: Enabling access in uncharted territory
Leong TD, McGee SM, Gray AL, de Waal R, Kredo T, Cohen K, Reubenson G, Blockman M, Nel J, Maartens G, Rees H, Wiseman R, Jamaloodien K, Parrish AG
Performance of the Swede score to predict cervical intraepithelial neoplasia in women with HIV-1 in Johannesburg, South Africa
Maringa VD, Chikandiwa A, Gilham C, Mbodi L, Kelly H, Mayaud P, Delany-Moretlwe S, Adam Y
CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz
Griesel R, Maartens G, Chirehwa M, Sokhela S, Akpomiemie G, Moorhouse M, Venter F, Sinxadi P
High individual pain variability in people living with HIV: A graphical analysis
Wadley AL, Venter W, Moorhouse M, Akpomiemie G, Serenata C, Hill A, Sokhela S, Mqamelo N, Kamerman PR
The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV
Rojo P, Carpenter D, Venter F, Turkova A, Penazzato M
Southern African HIV Clinicians Society guidelines for solid organ transplantation in human immunodeficiency virus: An evidence-based framework for human immunodeficiency virus-positive donors and recipients
Nel JS , Conradie F, Botha J, Etheredge H, Fabian J, Levin L, Mazanderani AH, Moorhouse M, Muller E, Tiemessen C, Thomson D, Turner J
Risk factors for loss to follow-up from antiretroviral therapy programmes in low-income and middle-income countries
Frijters EM, Hermans LE, Wensing AMJ, Devillé WLJM, Tempelman HA, De Wit JBF
South African adolescent girls and young womens narratives on the value of HIV prevention peer support clubs
Baron D, Scorgie F, Ramskin L, Khoza N, Schutzman J, Stangl A, Harvey S, Delany-Moretlwe S
Measuring linkage to HIV treatment services following HIV self‐testing in low‐income settings
Choko AT, Jamil MS, MacPherson P, Corbett E, Chitembo L, Ingold H, Bermudez Aza E, d’Elbee M, DiCarlo M, Majam M, Schewchuk T, Wong V, Baggaley R, Johnson C; World Health Organization HIV self-testing technical working group
Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy Compared to Those Commenced on ART During Pregnancy
Theron G, Brummel S, Fairlie L, Pinilla M, McCarthy K, Owor M, Chinula L, Makanani B, Violari A, Moodley D, Chakhtoura N, Browning R, Hoffman R, Fowler MG; PROMISE (Promoting Maternal and Infant Survival Everywhere) 1077BF and 1077FF Teams
HIV testing, care and viral suppression among men who have sex with men and transgender individuals in Johannesburg, South Africa
Fearon E, Tenza S, Mokoena C, Moodley K, Smith AD, Bourne A, Weatherburn P, Palanee-Phillips T https://journals.plos.org/plosone/article/file?
Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study
van der Straten A, Ryan JH, Reddy K, Etima J, Taulo F, Mutero P, Taylor J, Piper J, Musara P; MTN-041/MAMMA Study Team
Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second line ART
Hermans LE, Steegen K, Ter Heine R, Schuurman R, Tempelman HA, Moraba R, van Maarseveen E, Nijhuis M, Pillay T, Legg-E’Silva D, Snyman T, Schapiro JM, Burger DM, Carmona S, Wensing AM
Human papillomavirus seroprevalence and seroconversion among men living with HIV: Cohort study in South Africa
Chikandiwa A, Faust H, Chersich MF, Mayaud P, Dillner J, Delany-Moretlwe S
The cost-effectiveness of HIV pre-exposure prophylaxis among heterosexual men in South Africa: a cost-utility modelling analysis
Vogelzang M, Terris-Prestholt F, Vickerman P, Delany-Moretlwe S, Travill D, Quaife M
Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission.
Nyakato P, Davies MA, Technau KG, Fatti G, Rabie H, Tanser F, Boulle A, Wood R, Eley B, Sawry S, Giddy J, Sipambo N, Kuhn L, Fairlie L; International epidemiology Database to Evaluate AIDS-Southern Africa (IeDEA-SA) Collaboration
Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial
Beesham I, Welch JD, Heffron R, Pleaner M, Kidoguchi L, Palanee-Phillips T, Ahmed K, Baron D, Bukusi EA, Louw C, Mastro TD, Smit J, Batting JR, Malahleha M, Bailey VC, Beksinska M, Donnell D, Baeten JM; ECHO Trial Consortium.
The state of mind tells me it’s dirty- menstrual shame amongst women using a vaginal ring in Sub Saharan Africa
Zoe Duby, Ariana Katz, Petina Musara, Josephine Nabukeera, Chifundo Colleta Zimba, Kubashni Woeber, Thesla Palanee-Phillips & Ariane van der Straten (2019)
The same lesson over and over: drugs alone will not get us to 90-90-90
Cohen J, Pepperrell T, Venter FWD
Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa
Pillay D, Stankevitz K, Lanham M, Ridgeway K, Murire M, Briedenhann E, Jenkins S, Subedar H, Hoke T, Mullick S
Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis
Kelly H, Chikandiwa A, Alemany Vilches L, Palefsky JM, de Sanjose S, Mayaud P.
Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemic
Pepperrell T, Hill A, Moorhouse M, Clayden P, McCann K, Sokhela S, Serenata C, Venter WDF
Cardiovascular Disease Burden in Rural Africa: Does HIV and Antiretroviral Treatment Play a Role?: Baseline Analysis of the Ndlovu Cohort Study
Vos AG, Barth RE, Klipstein-Grobusch K, Tempelman HA, Devillé WLJ, Dodd C, Coutinho RA, Grobbee DE; Ndlovu Research Consortium
Implementation of a PMTCT programme in a high HIV prevalence setting in Johannesburg, South Africa
Mnyani CN, Tait CL, Peters RPH, Struthers H, Violari A, Gray G, Buchmann EJ, Chersich MF, McIntyre JA
Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities
Reddy K, Kelly C, Brown ER, Jeenarain N, Naidoo L, Siva S, Bekker LG, Nair G, Makanani B, Chinula L, Mgodi N, Chirenje Z, Kiweewa FM, Marrazzo J, Bunge K, Soto-Torres L, Piper J, Baeten JM, Palanee-Phillips T; MTN-020/ASPIRE and MTN-003/VOICE Study Teams
The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study
Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K, Mangxilana N, Nobula L, Bulterys MA, Atujuna M, Hosek S, Heffron R, Bekker LG, Mgodi N, Chirenje M, Celum C, Delany-Moretlwe S; HPTN 082 study group Introduction: Stigma and disclosure concerns have been key barriers to oral pre-exposure…
Disclosure of PrEP use by young women in South Africa and Tanzania: qualitative findings from a demonstration project
Scorgie F, Khoza N, Baron D, Lees S, Harvey S, Ramskin L, Stangl A, Colombini M, Mashauri E, Delany-Moretlwe S; EMPOWER study team
Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study
Hermans LE, Carmona S, Nijhuis M, Tempelman HA, Richman DD, Moorhouse M, Grobbee DE, Venter WDF, Wensing AMJ
ECHO Trial Consortium.ECHO: context and limitations
Baeten JM, Kiarie J, Mastro TD, Mugo NR, Rees H;
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines
Phillips AN, Bansi-Matharu L, Venter F, Havlir D, Pozniak A, Kuritzkes DR, Wensing A, Lundgren JD, Pillay D, Mellors J, Cambiano V, Jahn A, Apollo T, Mugurungi O, Ripin D, Da Silva J, Raizes E, Ford N, Siberry GK, Gupta RK, Barnabas R, Revill P, Cohn J, Calmy A, Bertagnolio…
Fertility Intentions and Clinical Care Attendance Among Women Living with HIV in South Africa
Rucinski KB, Schwartz SR, Powers KA, Pence BW, Chi BH, Black V, Rees H, Pettifor AE
Trajectories of fertility intentions among women living with HIV in South Africa
Rucinski KB, Powers KA, Pettifor AE, Black V, Pence BW, Chi BH, Rees H, Schwartz SR
Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006-2017
Iyun V, Technau KG, Eley B, Rabie H, Boulle A, Fatti G, Egger M, Tanser F, Wood R, Fairlie L, Cotton MF, Davies MA
Time to rethink endpoints for new clinical trials of antiretrovirals? Long-term re-suppression of HIV RNA with integrase inhibitors
Pepperrell T, Venter WDF, Moorhouse M, McCann K, Bosch B, Tibbatts M, Woods J, Sokhela S, Serenata C, Hill A
Abacavir exposure in children co-treated for tuberculosis with rifampicin and super-boosted lopinavir-ritonavir. Antimicrobial Agents and Chemotherapy
Rabie H, Tikiso T, Lee J, Fairlie L, Strehlau R, Bobat R, Liberty A, McIlleron H, Andrieux-Meyer I, Cotton M, Lallemant M, Denti P
The Mediating Role of Partner Selection in the Association Between Transactional Sex and HIV Incidence Among Young Women
Ranganathan M, Kilburn K, Stoner MCD, Hughes JP, MacPhail C, Gomez-Olive FX, Wagner RG, Kahn K, Agyei Y, Pettifor A
The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial
Atuhaire P, S Brummel S, Mmbaga BT, Angelidou K, Fairlie L, Violari A, Theron G, Mukuzunga C, Mawlana S, Mubiana-Mbewe M, Naidoo M, Makanani B, Mandima P, Nematadzira T, Suryavanshi N, Mbengeranwa T, Loftis A, Basar M, McCarthy K, Currier JS, Fowler MG; 1077BF/1077FF PROMISE Team
Characterizing the double-sided cascade of care for adolescents living with HIV transitioning to adulthood across Southern Africa
Tsondai PR, Sohn AH, Phiri S, Sikombe K, Sawry S, Chimbetete C, Fatti G, Hobbins MA, Technau KG, Rabie H, Bernheimer J, Fox MP, Judd A, Collins IJ, Davies MA; International epidemiology to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration.
The Power of the Shared Experience: MTN-020/ASPIRE Trial Participants’ Descriptions of Peer Influence on Acceptability of and Adherence to the Dapivirine Vaginal Ring for HIV Prevention
Katz AWK, Naidoo K, Reddy K, Chitukuta M, Nabukeera J, Siva S, Zimba C, Montgomery ET
Implementation of a fidelity monitoring process to assess delivery of an evidence-based adherence counseling intervention in a multi-site biomedical HIV prevention study
Duby Z, Katz A, Musara P, Nabukeera J, Zimba CC, Woeber K, Palanee-Phillips T, van der Straten A
Topical delivery of long-acting antiretrovirals to prevent HIV acquisition
Palanee-Phillips T, Baeten JM
Cardiovascular disease risk and its determinants in people living with HIV across different settings in South Africa
Roozen G, Vos AG, Tempelman HA, Venter W, Grobbee DE, Scheuermaier K, Klipstein-Grobusch K. (2019)
African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected
Boivin MJ, Chernoff M, Fairlie L, Laughton B, Zimmer B, Joyce C, Barlow-Mosha L, Bwakura-Dangarembizi M, Vhembo T, Ratswana M, Kamthunzi P, McCarthy K, Familiar-Lopez I, Jean-Philippe P, Coetzee J, Abrahams N, Gous H, Violari A, Cotton MF, Palumbo PE.(2019)
Prevalent, persistent anal HPV infection and squamous intraepithelial lesions: Findings from a cohort of men living with HIV in South Africa
Chikandiwa A, Pisa PT, Tamalet C, Muller EE, Michelow P, Chersich MF, Mayaud P, Delany-Moretlwe S. (2019)
Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females
Jesson J, Schomaker M, Malasteste K, Wati DK, Kariminia A, Sylla M, Kouadio K, Sawry S, Mubiana-Mbewe M, Ayaya S, Vreeman R, McGowan CC, Yotebieng M, Leroy V, Davies MA, IeDEA global cohort consortium. (2019)
Descriptive analysis of World Health Organization-recommended second-line antiretroviral treatment: A retrospective cohort data analysis.
Gumede SB, Fischer A, Venter WDF, Lalla-Edward ST. (2019)
HIV immunoprophylaxis: preparing the pathway from proof of concept to policy decision and use
Vekemans J, Snow W, Fast PE, Baggaley R, Chinyenze K, Friede MH, Godfrey-Faussett P, Kaslow DC, Rees H. (2019)
Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis
Meyers T, Samson P, Acosta EP, Moye J, Townley E, Bradford S, Marillo L, Denson K, Hovind L, Sise T, Teppler H, Mathiba SR, Masenya M, Hesseling A, Cotton MF, Krogstad P, IMPAACT P1101 Team. (2019)
The Utility of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Assay in Detecting Abnormalities in Lipid Metabolism and Cardiovascular Risk in an HIV-Infected South African Cohort
Mayne ES, Moabi H, Grobbee DE, Barth RE, Klipstein-Grobusch K, Stevens WS, Vos AG, Louw S. (2019)
Current perspectives on paediatric HIV management from the Mexico International Aids Society Conference, 2019
Archary M, Fairlie L, Slogrove A. (2019)
The estimated burden of fungal disease in South Africa
Schwartz S, Boyles TH, Kenyon CR, Hoving JC, Brown GD, Denning DW. (2019)
Impact of Male Partner Involvement on Womens Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial
Roberts ST, Nair G, Baeten JM, Palanee-Philips T, Schwartz K, Reddy K, Kabwigu S, Matovu Kiweewa F, Govender V, Gaffoor Z, Singh N, Siva S, Naidoo K, Montgomery ET; for the MTN-020/ASPIRE Team. (2019)
Time to strengthen HIV treatment and prevention for youth
Pettifor A, Filiatreau L, Delany-Moretlwe S. (2019)
Unexpected low frequency of respiratory symptoms in an HIV-positive urban sub-Saharan population
Kummerow M, Shaddock EJ, Klipstein-Grobusch K, Barth RB, Grobbee DE, Venter FDF, Feldman C, Vos A. (2019)
Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya
Rosen S, Maskew M, Larson BA, Brennan AT, Tsikhutsu I, Fox MP, Vezi L, Bii M, Venter WDF. (2019)
Comprehensive HIV risk reduction interventions for 2020 and beyond: product choices and effective service-delivery platforms for individual needs and population-level impact
Velloza J, Delany-Moretlwe S, Baeten JM. (2019)
Who is seeking antiretroviral treatment for HIV now: Characteristics of patients presenting in Kenya and South Africa in 2017-2018
Brennan AT, Maskew M, Larson BA, Tsikhutsu I, Bii M, Vezi L, Fox MP, Venter WD, Ehrenkranz P, Rosen S. (2019)
Prevalence and Antimicrobial Resistance of Mycoplasma genitalium Infection Among Women Living With Human Immunodeficiency Virus in South Africa
Ong JJ, Magooa MP, Chikandiwa A, Kelly H, Didelot MN, Muller EE, Maseko V, Segondy M, Delany-Moretlwe S, Kularatne R, Mayaud P, HIV in Africa Research Partnership Study Group. (2019)
A trip down memory lane with Retrovirology
Benkirane M, Berkhout B, Borrow P, Fassati A, Fujii M, Garcia-Martinez JV, Margolis D, Nijhuis M, Parent L, Strebel K, Venter F, Kirchhoff F, Lever A, Ross S, Mak J. (2019)
Association between caregiver depression symptoms and child executive functioning. Results from an observational study carried out in four sub-Saharan countries
Familiar I, Chernoff M, Ruisenor-Escudero H, Laughton B, Joyce C, Fairlie L, Vhembo T, Kamthunzi P, Barlow-Barlow L, Zimmer B, McCarthy K, Boivin MJ. (2019)
The effects of a physiotherapist-led exercise intervention on peripheral neuropathy among people living with HIV on antiretroviral therapy in Kigali, Rwanda
Tumusiime DK, Stewart A, Venter F, Musenge E.(2019)
Prevalence of Dyslipidaemia in HIV-infected Children Treated with Protease Inhibitors in South Africa
Sipambo N, Coovadia A, Meyers T, Sawry S. (2019)
Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study
Palanee-Phillips T, Brown ER, Szydlo D, Matovu Kiweewa F, Pather A, Harkoo I, Nair G, Soto-Torres L, Hillier SL, Baeten JM, MTN-020/ASPIRE Study Team. (2019)
A descriptive analysis of the role of a WhatsApp clinical discussion group as a forum for continuing medical education in the management of complicated HIV and TB clinical cases in a group of doctors in the Eastern Cape, South Afric
Woods J, Moorhouse M, Knight L. (2019)
Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL- WRHI 052: a randomised, open-label, phase 3, non-inferiority trial
Venter WDF, Moorhouse M, Sokhela S, Serenata C, Akpomiemie G, Qavi A, Mashabane N, Arulappan N, Sim JW, Sinxadi PZ, Wiesner L, Maharaj E, Wallis C, Boyles T, Ripin D, Stacey S, Chitauri G, Hill A. (2019)
Healthcare seeking behaviour for common infectious syndromes among people in three administrative regions of Johannesburg, South Africa
Mapuroma R, Cohen C, Kuonza L, Musekiwa A, Tempia S, Tshangela A, von Mollendorf C. (2019)
Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission
Williams-Wietzikoski C, Campbell M, Payant R, Lam A, Zhao H, Huang H, Mullins J, Wald A, Stevens W, Gray G, Farquhar C, Rees H, Celum C, Lingappa J, Frenkel L. (2019)
Community Inclusion in PrEP Demonstration Projects: Lessons for Scaling Up
Reza-Paul S, Lazarus L, Jana S, Ray P, Mugo N, Ngure K, Folayan M O, Durueke F, Idoko J, Béhanzin L, Alary M, Gueye D, Sarr, Mukoma W, Kyongo JK, Bothma R, Eakle R, Dallabetta G, Presley J, Lorway R. (2019)
Clients experiences utilizing a safer conception service for HIV affected individuals: implications for differentiated care service delivery models
Schwartz S, Davies N, Naidoo N, Pillay D, Makhoba N, Mullick S. (2019)
Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.
Pleasants E, Tauya T, Reddy K, Mirembe BG, Woeber K, Palanee-Phillips T, Zimba C, Atujuna M, Montgomery ET; MTN-020/ASPIRE Study Team
Why South Africa urgently needs to support the development of pregnancy exposure registries
Mehta U, Kalk E, Fairlie L, Boulle A, Rees H. (2019)
What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies
Patten G, Schomaker M, Davies MA, Rabie H, van Zyl G, Technau K, Eley B, Boulle A, Van Dyke RB, Patel K, Sipambo N, Wood R, Tanser F, Giddy J, Cotton M, Nuttall J, Essack G, Karalius B, Seage G, Sawry S, Egger M, Fairlie L.(2019)
Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa
Selinger C, Bershteyn A, Dimitrov DT, Adamson BJS, Revill P, Hallett TB, Phillips AN, Bekker LG, Rees H, Gray G. (2019)
Improving Linkage to and Retention in Care in Newly Diagnosed HIV-Positive Patients Using Smartphones in South Africa: Randomized Controlled Trial
Venter WDF, Fischer A, Lalla-Edward ST, Coleman J, Lau Chan V, Shubber Z, Phatsoane M, Gorgens M, Stewart-Isherwood L, Carmona S, Fraser-Hurt N. (2019)
Early Infant Diagnosis HIV-1 PCR Cycle-threshold Predicts Infant Viral Load at Birth
Mazanderani AH, Kufa T, Technau KG, Strehlau R, Patel F, Shiau S, Burke M, Kuhn L, Abrams EJ, Sherman G. (2019)
Qualitative assessment of South African healthcare worker perspectives on an instrument-free rapid CD4 test
Scorgie F, Mohamed Y, Anderson D, Crowe SM, Luchters S, Chersich MF.(2019)
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
Phillips AN, Venter F, Havlir D, Pozniak A, Kuritzkes D, Wensing A, Lundgren JD, De Luca A, Pillay D, Mellors J, Cambiano V, Bansi-Matharu L, Nakagawa F, Kalua T, Jahn A, Apollo T, Mugurungi O, Clayden P, Gupta RK, Barnabas R, Revill P, Cohn J, Bertagnolio S, Calmy A. (2019)
Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
Gossez M, Martin GE, Pace M, Ramjee G, Premraj A, Kaleebu P, Rees H, Inshaw J, Stöhr W, Meyerowitz J, Hopkins E, Jones M, Hurst J, Porter K, Babiker A, Fidler S, Frater J, SPARTAC Trial Investigators.(2019)
Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial
Venter WDF, Kambugu A, Chersich MF, Becker S, Hill A, Arulappan N, Moorhouse M, Majam M, Akpomiemie G, Sokhela S, Poongulali S, Feldman C, Duncombe C, Ripin DHB, Vos A, Kumarasamy N.(2019)
The diagnosis of tuberculous meningitis in adults and adolescents: protocol for a systematic review and individual patient data meta-analysis to inform a multivariable prediction model
Boyles T, Stadelman A, Ellis JP, Cresswell FV, Lutje V, Wasserman S, Tiffin N, Wilkinson R. (2019)
Field Performance and Diagnostic Accuracy of a Low-Cost Instrument-Free Point-of-Care CD4 Test – Visitect CD4 Performed by Different Health Worker Cadres among Pregnant Women
Luchters S, Technau K, Mohamed Y, Chersich MF, Agius PA, Pham MD, Garcia ML, Forbes J, Shepherd A, Coovadia A, Crowe SM, Anderson DA. (2019)
The association between HIV infection and pulmonary function in a rural African population
Varkila MRJ, Vos AG, Barth RE, Tempelman HA, Devillé WLJ, Coutinho RA, Grobbee DE, Klipstein-Grobusch K. (2019)
Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes
Moorhouse M, Maartens G, Venter WDF, Moosa MY, Steegen K, Jamaloodien K, Fox MP, Conradie F. (2019)
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)
Seddon JA, Garcia-Prats AJ, Purchase SE, Osman M, Demers AM, Hoddinott G, Crook AM, Owen-Powell E, Thomason MJ, Turkova A, Gibb DM. (2018)
Longitudinal patterns of unmet need for contraception among women living with HIV on antiretroviral therapy in South Africa
Rucinski KB, Powers KA, Schwartz SR, Pence BW, Chi BH, Black V, Rees H, Pettifor AE. (2018)
Impact of partner-related social harms on women’s adherence to the dapivirine vaginal ring during a phase III trial
Palanee-Phillips T, Roberts ST, Reddy K, Govender V, Naidoo L, Siva S, Gafoor Z, Pather A, Matovu F, Hlahla K, Makanani B, Nair G, Schwartz K, Torjesen K, Brown E, Soto-Torres L, Baeten J, Elizabeth T Montgomery ET, MTN-020/ASPIRE Team. (2018)
Pregnancy and infant outcomes among women using the dapivirine vaginal ring in early pregnancy
Makanani B, Balkus JE, Jiao Y, Noguchi LM, Palanee-Phillips T, Mbilizi Y, Moodley J, Kintu K, Reddy K, Kabwigu S, Jeenariain N, Kabwigu S, Jeenariain N, Beigi R, Baeten JM. (2018)
Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir
Vos AG, Chersich MF, Klipstein-Grobusch K, Zuithoff P, Moorhouse MA, Lalla-Edward ST, Kambugu A, Kumarasamy N, Grobbee DE, Barth RE, Venter WD. (2018)
Effects of Tobacco Usage and Antiretroviral Therapy on Biomarkers of Systemic Immune Activation in HIV Infected Participants
Steel HC, Venter WDF, Theron AJ, Anderson R, Feldman C, Kwofie L, Cronjé T, Arullapan N, Rossouw TM (2018)
Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir–ritonavir without rifampicin: a pharmacokinetic modelling and clinical study
Rabie H, Denti P, Lee J, Masango M, Coovadia A, Pillay S, Liberty A, Simon F, McIlleron H, Cotton MF, Lallemant M. (2018)
Characteristics associated with HIV transmission networks involving adolescent girls and young women in HIV Prevention Trials Network (HPTN) 068 study
Stoner MC, Dennis AM, Hughes JP, Eshleman SH, Sivay MV, Hudelson SE, Kate MG, Gomez-Olive X, MacPhail C, Piwowar-Manning E, Kahn K, Pettifor A (2018)
‘It’s because I like things… it’s a status and he buys me airtime’: exploring the role of transactional sex in young women’s consumption patterns in rural South Africa (secondary findings from HPTN 068)
Ranganathan M, Heise L, MacPhail C, Stöckl H, Silverwood RJ, Kahn K, Selin A, Gómez-Olivé FX, Watts C, Pettifor A. (2018)
Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation
Panayidou K, Davies MA, Anderegg N, Egger M, IeDEA, COHERE, PHACS and IMPAACT 219C Collaborations Writing Group. (2018)
Developing a model for integrating sexual and reproductive health services with HIV prevention and care in KwaZulu-Natal, South Africa
Milford C, Scorgie F, Greener LR, Mabude Z, Beksinska M, Harrison A, Smit J.(2018)
PrEP Communications Accelerator: a digital demand creation tool for sub-Saharan Africa
Schwartz K, Ferrigno B, Vining S, Gomez A, Briedenhann E, Gardiner E, Jeckonia P, Torjesen K. (2018)
An overview of tenofovir and renal disease for the HIV-treating clinician
Venter WDF, Fabian J, Feldman C.(2018)
Evaluation of the intensified tuberculosis case finding guidelines for children living with HIV
Sawry S, Moultrie H, Van Rie A. (2018)
Village community mobilization is associated with reduced HIV incidence in young South African women participating in the HPTN 068 study cohort
Lippman SA, Leddy AM, Neilands TB, Ahern J, MacPhail C, Wagner RG, Peacock D, Twine R, Goin DE, Gómez-Olivé FX, Selin A, Tollman SM, Kahn K, Pettifor A. (2018)
Lamivudine monotherapy as a holding regimen for HIV-positive children
Fairlie L, Rabie H, Sawry S, Technau K, Eley B, Davies MA, IeDEA Southern Africa. (2018)
Improved simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE II): protocol for a randomized evaluation
Rosen S, Maskew M, Brennan AT, Fox MP, Vezi L, Ehrenkranz PD, Venter WD. (2018)
Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
Moorhouse MA, Carmona S, Davies N, Dlamini S, Van Vuuren C, Manzini T, Mathe M, Moosa Y, Nash J, Nel J, Pakade Y, Woods J, van Zyl G, Conradie F, Venter F, Meintjes G. (2018)
Appropriate clinical use of darunavir 800 mg. Southern African journal of HIV medicine
Moorhouse MA, Carmona S, Davies N, Dlamini S, van Vuuren C, Manzini T, Mathe M, Moosa Y, Nash J, Nel J, Pakade Y.(2018)
Does Partner Selection Mediate the Relationship Between School Attendance and HIV/Herpes Simplex Virus-2 Among Adolescent Girls and Young Women in South Africa: An Analysis of HIV Prevention Trials Network 068 Data
Stoner MC, Edwards JK, Miller WC, Aiello AE, Halpern CT, Julien A, Rucinski KB, Selin A, Twine R, Hughes JP, Wang J. Agyei Y, Gómez-Olivé FX, Wagner RG, Laeyendecker O, Macphail C, Kahn K, Audrey Pettifor A. (2018)
Building capacity in neurodevelopment assessment of children in sub-Saharan Africa: A quality assurance model to implement standardized neurodevelopment testing
Ruiseñor-Escudero H, Familiar I, Nyakato M, Kutessa A, Namukooli J, Ssesanga T, Joyce C, Laughton B, Grab J, Chernoff M, Vhembo T, Fairlie L, Kamthunzi P, Boivin M, IMPAACT P1104s team. (2018)
Building capacity in neurodevelopment assessment of children in sub-Saharan Africa
Ruiseñor-Escudero H, Familiar I, Nyakato M, Kutessa A, Namukooli J, Ssesanga T, Joyce C, Laughton B, Grab J, Chernoff M, Vhembo T, Fairlie L, Kamthunzi P, Boivin M, IMPAACT P1104s team. (2018)
Changes to the WHO guidelines for hormonal contraceptive eligibility for women at high risk for HIV: The South African perspective and response
Nene Z, Hofmeyer GJ, Patel M, Panday M, Rees H, Makua M, Pillay Y.(2018)
Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results
Montgomery ET, Stadler J, Naidoo S, Katz AW, Laborde N, Garcia M, Reddy K, Mansoor LE, Etima J, Zimba C, Chitukuta M, Soto-Torres L. (2018)
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Chiotan DI, Crossa A, Drobac PC,Fairlie L, Falzon D, et al. (2018)
Improving Linkage to HIV Care Through Mobile Phone Apps: Randomized Controlled Trial
Venter W, Coleman J, Chan VL, Shubber Z, Phatsoane M, Gorgens M, Stewart-Isherwood L, Carmona S, Fraser-Hurt N.(2018)
Characterizing the Patterns of HIV Disclosure to Clients Among South African Female Sex Workers in Port Elizabeth.
Wells C, Schwartz S, Phaswana-Mafuya N, Lambert A, Kose Z, Mcingana M, Hausler H, Rao A, Yah C, Ketende S, Baral S.
Changes to the World Health Organization guideline on hormonal contraceptive eligibility for women at high risk of HIV: South African perspective and response
Nene Z, Hofmeyr G, Patel M, Panday M, Rees H, Majua M ,Pillay Y.
The effect of HIV prevention products on incentives to supply condomless commercial sex among female sex workers in South Africa.
Quaife M, Vickerman P, Manian S, Eakle R, Cabrera‐Escobar Maria A, Delany‐Moretlwe S
“It Was Not My Aim to Sleep There”: The Impact of Timing and Location of Sex on Adherence to Coitally-Dependent HIV Pre-exposure Prophylaxis.
Scorgie F, Stadler J, Baron D, Ju S, Ikaneng T, Mabude Z, Makgopa S, Malefo MA, Manenzhe KN, Mazibuko T, Ntjana H.
The cost‐effectiveness of multi‐purpose HIV and pregnancy prevention technologies in South Africa.
Quaife, M., Terris‐Prestholt, F., Eakle, R., Cabrera Escobar, M. A., Kilbourne‐Brook, M., Mvundura, M., Meyer‐Rath, G., Delany‐Moretlwe, S. and Vickerman, P. J Int AIDS Soc. 2018; 21(3):e25064
Risk perception and the influence on uptake and use of biomedical prevention interventions for HIV in sub-Saharan Africa: A systematic literature review.
Warren EA, Paterson P, Schulz WS, Lees S, Eakle R, Stadler J, Larson HJ.
‘Hold on’ (Bambelela)! Lyrical interpretations of participation in an HIV prevention clinical tria
Stadler J, MacGregor H, Saethre E, Delany-Moretlwe
Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa.
Tan N, Sharma M, Winer R, Galloway D, Rees H, Barnabas RV. Vaccine. d.
Time to First-Line ART Failure and Time to Second-Line ART Switch in the IeDEA Pediatric Cohort.
Wools-Kaloustian K, Marete I, Ayaya S, Sohn AH, Van Nguyen L, Li S, Leroy V, Musick BS, Newman JE, Edmonds A, Davies MA.
Safety of a silicone elastomer vaginal rings as a potential microbicide delivery method in African women: A Phase 1 randomized trial.
Nel A, Martins J, Bekker L-G, Ramjee G, Masenga G, Rees H, van Niekerk N.
Consensus statement: supporting safer conception and pregnancy for men and women living with and affected by HIV.
Matthews LT, Beyeza-Kashesya J, Cooke I, Davies N, Heffron R, Kaida A, Kinuthia J, Mmeje O, Semprini AE, Weber S.
The transition to dolutegravir and other new antiretrovirals in low-and middle-income countries-what are the issues?
Vitoria M, Hill A, Ford N, Doherty M, Clayden P, Venter F, Ripin D, Flexner C, Domanico P.
Optimizing adherence in HIV prevention product trials: Development and psychometric evaluation of simple tools for screening and adherence counseling.
Tolley EE, Guthrie KM, Zissette S, Fava JL, Gill K, Louw CE, Kotze P, Reddy K, MacQueen K.
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women…
Flynn PM, Taha TE, Cababasay M, Fowler MG, Mofenson LM, Owor M, Fiscus S, Stranix-Chibanda L, Coutsoudis A, Gnanashanmugam D, Chakhtoura N
The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.
Slogrove AL, Schomaker M, Davies MA, Williams P, Balkan S, Ben-Farhat J, Calles N, Chokephaibulkit K, Duff C, Eboua TF, Kekitiinwa-Rukyalekere A.
Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.
Torrone EA, Morrison CS, Chen PL, Kwok C, Francis SC, Hayes RJ, Looker KJ, McCormack S, McGrath N, van de Wijgert JH, Watson-Jones D.
Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women.
Pyra M, Lingappa JR, Heffron R, Erikson DW, Blue SW, Patel RC, Nanda K, Rees H, Mugo NR, Davis NL, Kourtis AP. 2018.(Epub ahead of print)
Evidence for sample selection effect and Hawthorne effect in behavioural HIV prevention trial among young women in a rural South African community.
Rosenberg M, Pettifor A, Twine R, Hughes JP, Gomez-Olive FX, Wagner RG, Sulaimon A, Tollman S, Selin A, MacPhail C, Kahn K.
Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study
Hermans LE, Moorhouse M, Carmona S, Grobbee DE, Hofstra LM, Richman DD, Tempelman HA, Venter WD, Wensing AM. (2017)
Prevalence and treatment outcomes of routine Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis testing during antenatal care, Gaborone, Botswana.
Wynn A, Ramogola-Masire D, Gaolebale P, Moshashane N, Sickboy O, Duque S, Williams E, Doherty K, Klausner JD, Morroni C.
Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial
Agwu AL, Warshaw MG, McFarland EJ, Siberry GK, Melvin AJ, Wiznia AA, Fairlie, Boyd S, Harding P, Spiegel HML, Abrams EJ, Carey VJ, P1094 Study Team. (2017)
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.
Iwuji CC, Orne-Gliemann J, Larmarange J, Balestre E, Thiebaut R, Tanser F, Okesola N, Makowa T, Dreyer J, Herbst K, McGrath N.
Working With Adolescents Living With HIV: A Toolkit For Healthcare Providers
Fick C, Fairlie L, Moultrie H, Woollett N, Pahad S, Thomson K, Pleaner M. (2017)
Evaluation of the prevention of mother-to-child transmission programme at a primary health care centre in South Africa
Akinsanya OS, Wiseberg-Firtell JA, Akpomiemie G, Adeniyi OV, Kaswa RP. (2017)
Potential barriers to rapid testing for human immunodeficiency virus among a commuter population in Johannesburg, South Africa
Tshuma N, Muloongo K, Setswe G, Chimoyi L, Safro B, Burger D, Nyasulu PS. (2015)
Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention
Kyongo JK, Crucitti T, Menten J, Hardy L, Cools P, Michiels J, Delany-Moretlwe S, Mwaura M, Ndayisaba G, Joseph S, Fichorova R, van de Wijgert J, Vanham G, Arien KK, Jespers V. (2015)
Declining maternal mortality in the face of persistently high HIV prevalence in a middle-income country
Buchmann EJ, Mnyani CN, Frank KA, Chersich MF, McIntyre JA. (2015)
Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm
Haberer JE, Bangsberg DR, Baeten JM, Curran K, Koechlin F, Amico KR, Anderson P, Mugo N, Venter F, Goicochea P. (2015)
Evolving Human Rights and the Science of Antiretroviral Medicine
Kavanagh MM, Cohn J, Mabote L, Meier BM, Williams B, Russell A, Sikwese K and Baker BK. (2015)
Epidemiological Trends for HIV in Southern Africa: Implications for Reaching the Elimination Targets
Williams BG, Gouws E, Somse P, Mmelesi M, Lwamba C, Chikoko T, Fazito E, Turay M, Kiwango E, Chikukwa P, Damisoni H, Gboun M. (2015)
Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment
Patel EU, Manucci J, Kahle EM, Lingappa JR, Morrow RA, Piwowar-Manning E, James A, Maluzi KF, Cheeba MM, Gray G, Delany-Moretlwe S, Inambao M, Vwalika B, Quinn TC, Laeyendecker O. (2015)
Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012
Porter M, Davies MA, Mapani MK, Rabie H, Phiri S, Nuttall J, Fairlie L, Technau KG, Stinson K, Wood R, Wellington M, Haas AD, Giddy J, Tanser F, Eley B. (2015)
Monitoring, Surveillance and Control of HIV drug resistance: the experience of a high burden country
Hunt G, Venter WDF, Morris L, Maartens G. (2015)
Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children
Van Rie A, Sawry S, Link‐Gelles R, Madhi S, Fairlie L, Verwey C, Mahomed N, Murdoch D, Moultrie H. (2015)
Programmatic Implications of Acute and Early HIV Infection
Suthar AB, Granich RM, Kato M, Nsanzimana S, Montaner JSG, Williams BG. (2019)
Rethinking HIV prevention to prepare for oral PrEP implementation for young African women
Celum CL, Delany-Moretlwe S, McConnell M, van Rooyen H, Bekker LG, Kurth A, Bukusi E, Desmond C, Morton J, Baeten JM. (2015)
Intimate partner violence and forced migration during pregnancy: Structural constraints to women’s agency
Turan JM, Hatcher AM, Romito P, Mangone E, Durojaiye M, Odero M, Camlin CS. (2015)
Pre-exposure prophylaxis in Southern Africa: feasible or not?
Venter WD, Cowan F, Black V, Rebe K, Bekker LG. (2015)
Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden; 1990–2013
Granich R, Gupta S, Hersh B, Williams B, Montaner J, Young B, Zuniga JM. (2015)
Morbidity and mortality of black HIV-positive patients with end-stage kidney disease
Fabian J, Maher HA, Clark C, Naicker S, Becker P, Venter WDF. (2015)
Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial
Barnabas RV, Baeten JM, Lingappa JR, Thomas KK, Hughes JP, Mugo NR, Delany-Moretlwe S, Gray G, Rees H, Mujugira A, Ronald A, Stevens W, Kapiga S, Wald A, Celum C. (2015)
Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention
Palanee-Phillips T, Schwartz K, Brown ER, Govender V, Mgodi N, Kiweewa FM, Nair G, Mhlanga F, Siva S, Bekker LG, Jeenarain N, Gaffoor Z, Martinson F, Makanani B, Naidoo S, Pather A, Phillip J, Husnik MJ, van der Straten A, Soto-Torres L, Baeten J. (2015)
Patterns of Lymph Node Pathology; Fine Needle Aspiration Biopsy as an Evaluation Tool for Lymphadenopathy: A Retrospective Descriptive Study Conducted at the Largest Hospital in Africa
Reddy DL, Venter WD, Pather S. (2015)
Starter Packs Versus Full Prescription of Antiretroviral Drugs for Postexposure Prophylaxis: A Systematic Review
Ford N, Venter F, Irvine C, Beanland RL, Shubber Z. (2015)
High incidence of latent tuberculous infection among South African health workers
McCarthy KM, Scott LE, Gous N, Tellie M, Venter WD, Stevens WS, Van Rie A. (2015)
Male Partner Influence on Women’s HIV Prevention Trial Participation and Use of Pre-exposure
Montgomery ET, van der Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, Laborde N, Soto-Torres L. (2015)
Modelling challenges in context: lessons from malaria, HIV, and tuberculosis
Childs LM, Abuelezam NN, Dye C, Gupta S, Murray MB, Williams BG, Buckee CO. (2015)
The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women
Jespers V, van de Wijgert J, Cools P, Verhelst R, Verstraelen H, Delany-Moretlwe S, Mwaura M, Ndayisaba GF, Mandaliya K, Menten J, Hardy L, Crucitti T, Vaginal Biomarkers Study Group. (2015)
Providing comprehensive health services for young key populations: needs, barriers and gaps
Delany-Moretlwe S, Cowan FM, Busza J, Bolton-Moore C, Kelley K, Fairlie L. (2015)
Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South Africa
Meyers T, Sawry S, Wong JY, Moultrie H, Pinillos F, Fairlie L, van Zyl G. (2015)
Estimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa
Jewell BL, Cremin I, Pickles M, Celum C, Baeten JM, Delany-Moretlwe S, Hallett TB. (2015)
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis
Morrison CS, Chen PL, Kwok C, Baeten JM, Brown J, Crook AM, Van Damme L, Delany-Moretlwe S, Francis SC, Friedland BA, Hayes RJ, Heffron R, Kapiga S, Karim QA, Karpoff S, Kaul R, McClelland RS, McCormack S, McGrath N, Myer L, Rees H, van der Straten A, Watson-Jones D, van…
HIV testing in the critical care setting: views of patients, family members and health providers
Martin C, Masote M, Hatcher A, Black V, Venter WD, Scorgie F. (2014)
Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir
Moultrie H, McIlleron H, Sawry S, Kellermann T, Wiesner L, Kindra G, Gous H, Van Rie A. (2014)
Footer
Established in 1994, Wits RHI is part of the Faculty of Health Sciences and the largest research institute of the University of the Witwatersrand.
Compliance
Information Hub
Contact us
Wits RHI Head Quarters,
Hillbrow Health Precinct,
22 Esselen Street
Hillbrow, 2001
Johannesburg
South Africa